Lateropulsion After Hemispheric Stroke: A Form of Spatial Neglect Involving Graviception.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
27 04 2021
Historique:
received: 25 02 2020
accepted: 28 01 2021
pubmed: 17 3 2021
medline: 11 5 2021
entrez: 16 3 2021
Statut: ppublish

Résumé

To test the hypothesis that lateropulsion is an entity expressing an impaired body orientation with respect to gravity in relation to a biased graviception and spatial neglect. Data from the DOBRAS cohort (ClinicalTrials.gov: NCT03203109) were collected 30 days after a first hemisphere stroke. Lateral body tilt, pushing, and resistance were assessed with the Scale for Contraversive Pushing. Among 220 individuals, 72% were upright and 28% showed lateropulsion (tilters [14%] less severe than pushers [14%]). The 3 signs had very high factor loadings (>0.90) on a same dimension, demonstrating that lateropulsion was effectively an entity comprising body tilt (cardinal sign), pushing, and resistance. The factorial analyses also showed that lateropulsion was inseparable from the visual vertical (VV), a criterion referring to vertical orientation (graviception). Contralesional VV biases were frequent (44%), with a magnitude related to lateropulsion severity: upright -0.6° (-2.9; 2.4), tilters -2.9° (-7; 0.8), and pushers -12.3° (-15.4; -8.5). Ipsilesional VV biases were less frequent and milder ( Lateropulsion (pusher syndrome) is a trinity constituted by body tilt, pushing, and resistance. It is a way to adjust the body orientation in the roll plane to a wrong reference of verticality. Referring to straight above, lateropulsion might correspond to a form of spatial neglect (referring to straight ahead), which would advocate for 3D maps in the human brain involving the internal model of verticality.

Identifiants

pubmed: 33722996
pii: WNL.0000000000011826
doi: 10.1212/WNL.0000000000011826
doi:

Banques de données

ClinicalTrials.gov
['NCT03203109']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2160-e2171

Informations de copyright

© 2021 American Academy of Neurology.

Auteurs

Shenhao Dai (S)

From the Neurorehabilitation Department, Institute of Rehabilitation (S.D., C.P., E.C., M.B., D.P.), Grenoble Alpes University Hospital; and Lab Psychology and NeuroCognition (S.D., C.P., M.B., D.P.) and AGEIS EA 7407 (M.H.), Université Grenoble Alpes, Grenoble, France.

Céline Piscicelli (C)

From the Neurorehabilitation Department, Institute of Rehabilitation (S.D., C.P., E.C., M.B., D.P.), Grenoble Alpes University Hospital; and Lab Psychology and NeuroCognition (S.D., C.P., M.B., D.P.) and AGEIS EA 7407 (M.H.), Université Grenoble Alpes, Grenoble, France.

Emmanuelle Clarac (E)

From the Neurorehabilitation Department, Institute of Rehabilitation (S.D., C.P., E.C., M.B., D.P.), Grenoble Alpes University Hospital; and Lab Psychology and NeuroCognition (S.D., C.P., M.B., D.P.) and AGEIS EA 7407 (M.H.), Université Grenoble Alpes, Grenoble, France.

Monica Baciu (M)

From the Neurorehabilitation Department, Institute of Rehabilitation (S.D., C.P., E.C., M.B., D.P.), Grenoble Alpes University Hospital; and Lab Psychology and NeuroCognition (S.D., C.P., M.B., D.P.) and AGEIS EA 7407 (M.H.), Université Grenoble Alpes, Grenoble, France.

Marc Hommel (M)

From the Neurorehabilitation Department, Institute of Rehabilitation (S.D., C.P., E.C., M.B., D.P.), Grenoble Alpes University Hospital; and Lab Psychology and NeuroCognition (S.D., C.P., M.B., D.P.) and AGEIS EA 7407 (M.H.), Université Grenoble Alpes, Grenoble, France.

Dominic Pérennou (D)

From the Neurorehabilitation Department, Institute of Rehabilitation (S.D., C.P., E.C., M.B., D.P.), Grenoble Alpes University Hospital; and Lab Psychology and NeuroCognition (S.D., C.P., M.B., D.P.) and AGEIS EA 7407 (M.H.), Université Grenoble Alpes, Grenoble, France. dperennou@chu-grenoble.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH